Article(id=1329914889759470167, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914828526826294, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.05.003, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1697040000000, receivedDateStr=2023-10-12, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795006018342, onlineDateStr=2026-11-18, pubDate=1715270400000, pubDateStr=2024-05-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795006018342, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795006018342, creator=13701087609, updateTime=1795006018342, updator=13701087609, issue=Issue{id=1329914828526826294, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='5', pageStart='593', pageEnd='742', issueExtLink='null', onlineDate='null', pubDate='1715270400000', pubDateStr='2024-05-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795006003743, creator='13701087609', updateTime=1795136133419, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330460632421348098, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914828526826294, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330460632421348099, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914828526826294, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=612, endPage=619, ext={EN=ArticleExt(id=1329914889939825240, articleId=1329914889759470167, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Research Progress in the Synthesis of Lemborexant, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Lemborexant(1) is an orexin receptor antagonist drug used for the treatment of insomnia. The chemical structure of this drug is relatively complex, with two chiral centers and a cyclopropane structure, which creates certain difficulties for chemical synthesis. This review analyzes and summarizes the synthesis routes of 1 from the perspective of how to construct chiral cyclopropane, using 3-fluorophenylacetonitrile(5), 2-bromo-5-fluorophenylacetic acid(20), allyl 2-(3-fluorophenyl)acetate(23) or methyl 3-fluorophenyl acetate(30) as the starting materials, with corresponding mechanism analysis in the key part and a brief overview of each route.

, authors=Zhongkui ZHANG, Shuzhen WANG, Naihua ZHANG, Xiaodong LU, Guimin ZHANG*, authorsList=Zhongkui ZHANG, Shuzhen WANG, Naihua ZHANG, Xiaodong LU, Guimin ZHANG, authorCompany=null, correspAuthors=Guimin ZHANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329914890229232217, articleId=1329914889759470167, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=莱博雷生的合成研究进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

莱博雷生(1)是一种用于治疗失眠症的食欲素受体拮抗药。该药物的化学结构比较复杂,存在2个手性中心及1个环丙烷结构,化学合成有一定的困难。文章从如何构建手性环丙烷的角度,以3-氟苯乙腈(5)、2-溴-5-氟苯乙酸(20)、2-(3-氟苯基)乙酸烯丙酯(23)或3-氟苯乙酸甲酯(30)为起始物料,对1的合成路线进行了分析和总结,并进行了相应的机制解析。

, authors=张仲奎, 王淑珍, 张乃华, 鹿晓东, 张贵民*, authorsList=张仲奎, 王淑珍, 张乃华, 鹿晓东, 张贵民, authorCompany=null, correspAuthors=张贵民, authorNote=

张仲奎(1987—),男,硕士,工程师,从事化学药物合成的研究。

, correspAuthorsNote=
张贵民(1969—),男,研究员,从事药物研发及工程化的研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=hupWZ4dcx+pyak44wpUsdA==, magXml=GN0B7N5au1rNNhS6ZsDV8w==, pdfUrl=null, pdf=zd7IPs0p32qOnIBlAaJKRA==, pdfFileSize=4106037, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=35Ug3bCrHZaQQ1PwO1u9PQ==, mapNumber=null, fund=null)}, authors=[Author(id=1329914890606719582, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914890690605664, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914890606719582, language=EN, stringName=Zhongkui ZHANG, firstName=Zhongkui, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914890745131617, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914890606719582, language=CN, stringName=张仲奎, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio={"content":"

张仲奎(1987—),男,硕士,工程师,从事化学药物合成的研究。

"}, bioImg=null, bioContent=

张仲奎(1987—),男,硕士,工程师,从事化学药物合成的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914890443141722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, xref=null, ext=[AuthorCompanyExt(id=1329914890451530331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329914890459918940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1329914890824823395, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914890879349349, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914890824823395, language=EN, stringName=Shuzhen WANG, firstName=Shuzhen, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914890946458214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914890824823395, language=CN, stringName=王淑珍, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914890443141722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, xref=null, ext=[AuthorCompanyExt(id=1329914890451530331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329914890459918940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1329914891005178472, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914891084870250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914891005178472, language=EN, stringName=Naihua ZHANG, firstName=Naihua, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914891147784811, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914891005178472, language=CN, stringName=张乃华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914890443141722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, xref=null, ext=[AuthorCompanyExt(id=1329914890451530331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329914890459918940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1329914891240059501, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914891311362671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914891240059501, language=EN, stringName=Xiaodong LU, firstName=Xiaodong, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914891382665840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914891240059501, language=CN, stringName=鹿晓东, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914890443141722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, xref=null, ext=[AuthorCompanyExt(id=1329914890451530331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329914890459918940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1329914891445580402, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=lunanzhangguimin@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914891516883572, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914891445580402, language=EN, stringName=Guimin ZHANG, firstName=Guimin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914891575603829, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914891445580402, language=CN, stringName=张贵民, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914890443141722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, xref=null, ext=[AuthorCompanyExt(id=1329914890451530331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329914890459918940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])])], keywords=[Keyword(id=1329914891667878518, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, language=EN, orderNo=1, keyword=lemborexant), Keyword(id=1329914891730793079, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, language=EN, orderNo=2, keyword=insomnia), Keyword(id=1329914891781124728, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, language=EN, orderNo=3, keyword=orexin receptor antagonist), Keyword(id=1329914891844039289, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, language=EN, orderNo=4, keyword=synthesis), Keyword(id=1329914891915342458, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, language=EN, orderNo=5, keyword=research progress), Keyword(id=1329914891974062715, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, language=CN, orderNo=1, keyword=莱博雷生), Keyword(id=1329914892032782972, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, language=CN, orderNo=2, keyword=失眠症), Keyword(id=1329914892095697533, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, language=CN, orderNo=3, keyword=食欲素受体拮抗药), Keyword(id=1329914892154417790, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, language=CN, orderNo=4, keyword=合成), Keyword(id=1329914892213138047, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, language=CN, orderNo=5, keyword=研究进展)], refs=[Reference(id=1329914892301218432, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=易红红,易锐,陈卓.食欲素受体及其抑制剂的研究进展[J].中国新药杂志,2017,26(12):1398-1405., articleTitle=null, refAbstract=null), Reference(id=1329914892385104513, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=刘晓盈,倪文骐.食欲素受体拮抗剂治疗失眠的研究进展[J].中国临床保健杂志,2023,26(1):140-144., articleTitle=null, refAbstract=null), Reference(id=1329914892464796290, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=OI N, SUZUKI M, TERAUCHI T, et al.Synthesis and evaluation of novel radioligands for positron emission tomography imaging of the orexin-2 receptor [J].J Med Chem, 2013, 56(16): 6371-6385., articleTitle=null, refAbstract=null), Reference(id=1329914892536099459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=相延英,金晓东,张燕,等.苏沃雷生的合成图解[J].中国医药工业杂志,2016,47(4):489-492., articleTitle=null, refAbstract=null), Reference(id=1329914892636762756, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=陈本川.治疗睡眠障碍新药—盐酸达利雷生(daridorexant hydrochloride)[J].医药导报,2022,41(9):1401-1407., articleTitle=null, refAbstract=null), Reference(id=1329914892699677317, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.药物临床试验登记与信息公示平台[EB/OL].[2022-02-02]. http://www.chinadrugtrials.org.cn/clinicaltrials.searchlistdetail.dhtml., articleTitle=null, refAbstract=null), Reference(id=1329914892770980486, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Eisai Co., Ltd.有价证券报告书・半年报告书・季度报告书[EB/OL].[2022-02-14].https://www.eisai.co.jp/ir/library/securities/pdf/pdf111fr_3.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914894721331847, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Eisai R&D Management Co., Ltd.Cyclopropane compound: WO, 2012039371A1 [P].2012-03-29., articleTitle=null, refAbstract=null), Reference(id=1329914894805217928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Eisai R&D Management Co., Ltd.Methods and compounds useful in the synthesis of orexin-2 receptor antagonists: WO, 2013123240A1 [P].2013-08-22., articleTitle=null, refAbstract=null), Reference(id=1329914894889104009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=YOSHIDA Y, TERAUCHI T, NAOE Y, et al.Design, synthesis, and structure-activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists [J].Bioorg Med Chem, 2014, 22(21): 6071-6088., articleTitle=null, refAbstract=null), Reference(id=1329914894972990090, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=YOSHIDA Y, NAOE Y, TERAUCHI T, et al.Discovery of (1R,2S)-2-[[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecar-boxamide(E2006): A potent and efficacious oral orexin receptor antagonist [J].J Med Chem, 2015, 58(11): 4648-4664., articleTitle=null, refAbstract=null), Reference(id=1329914895056876171, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Eisai R&D Management Co., Ltd.Method and compound useful in preparation of orexin-2 receptor antagonist and Lemborexant having few impurities: WO, 2020230800A1 [P].2020-11-19., articleTitle=null, refAbstract=null), Reference(id=1329914895203676812, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=CLEMENCEAU A, THESMAR P , GICQUEL M, et al.Direct synthesis of cyclopropanes from gem-dialkyl groups through double C-H activation [J].J Am Chem Soc, 2020, 142(36): 15355-15361., articleTitle=null, refAbstract=null), Reference(id=1329914895266591373, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=TOMOKAWA J, YAMAUCHI K.Method for manufacturing cyclopropane compound: WO, 2020050339A1 [P].2020-03-12., articleTitle=null, refAbstract=null), Reference(id=1329914895346283150, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=YU R R, CAI S Z, LI C, et al.Nickel-catalyzed asymmetric hydroaryloxy- and hydroalkoxycarbonylation of cyclopropenes [J].Angew Chem Int Ed Engl, 2022, 61(36): e202200733., articleTitle=null, refAbstract=null), Reference(id=1329914895409197711, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=沈冀钧,穆永乐,吴志鑫.一种莱博雷生中间体的制备方法:中国,116836120A [P].2023-10-03., articleTitle=null, refAbstract=null), Reference(id=1329914895480500880, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=沈冀钧,程虎,穆永乐.莱博雷生及其中间体化合物的制备方法:中国,116836150A [P].2023-10-03., articleTitle=null, refAbstract=null), Reference(id=1329914895547609745, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=沈冀钧,程虎,胡存良.莱博雷生及其中间体的制备方法:中国,116836151A [P].2023-10-03., articleTitle=null, refAbstract=null), Reference(id=1329914895623107218, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=沈冀钧,穆永乐,胡存良.莱博雷生及其中间体化合物的制备方法:中国,116836152A [P].2023-10-03., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329914890443141722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, xref=null, ext=[AuthorCompanyExt(id=1329914890451530331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329914890459918940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.05.003, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.05.003, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.05.003, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.05.003, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1715270400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
莱博雷生的合成研究进展
张仲奎 , 王淑珍 , 张乃华 , 鹿晓东 , 张贵民 *
中国医药工业杂志 | 综述 2024,55(5): 612-619
收起
收藏切换
中国医药工业杂志 |综述 2024 , 55 (5) : 612 -619
莱博雷生的合成研究进展
全屏
[Author(id=1329914890606719582, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914890690605664, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914890606719582, language=EN, stringName=Zhongkui ZHANG, firstName=Zhongkui, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914890745131617, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914890606719582, language=CN, stringName=张仲奎, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio={"content":"

张仲奎(1987—),男,硕士,工程师,从事化学药物合成的研究。

"}, bioImg=null, bioContent=

张仲奎(1987—),男,硕士,工程师,从事化学药物合成的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914890443141722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, xref=null, ext=[AuthorCompanyExt(id=1329914890451530331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329914890459918940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1329914890824823395, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914890879349349, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914890824823395, language=EN, stringName=Shuzhen WANG, firstName=Shuzhen, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914890946458214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914890824823395, language=CN, stringName=王淑珍, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914890443141722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, xref=null, ext=[AuthorCompanyExt(id=1329914890451530331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329914890459918940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1329914891005178472, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914891084870250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914891005178472, language=EN, stringName=Naihua ZHANG, firstName=Naihua, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914891147784811, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914891005178472, language=CN, stringName=张乃华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914890443141722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, xref=null, ext=[AuthorCompanyExt(id=1329914890451530331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329914890459918940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1329914891240059501, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914891311362671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914891240059501, language=EN, stringName=Xiaodong LU, firstName=Xiaodong, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914891382665840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914891240059501, language=CN, stringName=鹿晓东, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914890443141722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, xref=null, ext=[AuthorCompanyExt(id=1329914890451530331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329914890459918940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1329914891445580402, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=lunanzhangguimin@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914891516883572, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914891445580402, language=EN, stringName=Guimin ZHANG, firstName=Guimin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914891575603829, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, authorId=1329914891445580402, language=CN, stringName=张贵民, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914890443141722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, xref=null, ext=[AuthorCompanyExt(id=1329914890451530331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329914890459918940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914889759470167, companyId=1329914890443141722, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])])]
张仲奎, 王淑珍, 张乃华, 鹿晓东, 张贵民*
作者信息
  • 鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400
通讯作者:
张贵民(1969—),男,研究员,从事药物研发及工程化的研究。E-mail:
作者简介:

张仲奎(1987—),男,硕士,工程师,从事化学药物合成的研究。

Research Progress in the Synthesis of Lemborexant
Zhongkui ZHANG, Shuzhen WANG, Naihua ZHANG, Xiaodong LU, Guimin ZHANG*
Affiliations
  • National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi 273400
出版时间: 2024-05-10 doi: 10.16522/j.cnki.cjph.2024.05.003
文章导航
收藏切换

莱博雷生(1)是一种用于治疗失眠症的食欲素受体拮抗药。该药物的化学结构比较复杂,存在2个手性中心及1个环丙烷结构,化学合成有一定的困难。文章从如何构建手性环丙烷的角度,以3-氟苯乙腈(5)、2-溴-5-氟苯乙酸(20)、2-(3-氟苯基)乙酸烯丙酯(23)或3-氟苯乙酸甲酯(30)为起始物料,对1的合成路线进行了分析和总结,并进行了相应的机制解析。

莱博雷生  /  失眠症  /  食欲素受体拮抗药  /  合成  /  研究进展

Lemborexant(1) is an orexin receptor antagonist drug used for the treatment of insomnia. The chemical structure of this drug is relatively complex, with two chiral centers and a cyclopropane structure, which creates certain difficulties for chemical synthesis. This review analyzes and summarizes the synthesis routes of 1 from the perspective of how to construct chiral cyclopropane, using 3-fluorophenylacetonitrile(5), 2-bromo-5-fluorophenylacetic acid(20), allyl 2-(3-fluorophenyl)acetate(23) or methyl 3-fluorophenyl acetate(30) as the starting materials, with corresponding mechanism analysis in the key part and a brief overview of each route.

lemborexant  /  insomnia  /  orexin receptor antagonist  /  synthesis  /  research progress
张仲奎, 王淑珍, 张乃华, 鹿晓东, 张贵民. 莱博雷生的合成研究进展. 中国医药工业杂志, 2024 , 55 (5) : 612 -619 . DOI: 10.16522/j.cnki.cjph.2024.05.003
Zhongkui ZHANG, Shuzhen WANG, Naihua ZHANG, Xiaodong LU, Guimin ZHANG. Research Progress in the Synthesis of Lemborexant[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (5) : 612 -619 . DOI: 10.16522/j.cnki.cjph.2024.05.003

参考文献 引证文献
排序方式:
[1]
易红红,易锐,陈卓.食欲素受体及其抑制剂的研究进展[J].中国新药杂志,2017,26(12):1398-1405.
[2]
刘晓盈,倪文骐.食欲素受体拮抗剂治疗失眠的研究进展[J].中国临床保健杂志,2023,26(1):140-144.
[3]
OI N, SUZUKI M, TERAUCHI T, et al.Synthesis and evaluation of novel radioligands for positron emission tomography imaging of the orexin-2 receptor [J].J Med Chem, 2013, 56(16): 6371-6385.
[4]
相延英,金晓东,张燕,等.苏沃雷生的合成图解[J].中国医药工业杂志,2016,47(4):489-492.
[5]
陈本川.治疗睡眠障碍新药—盐酸达利雷生(daridorexant hydrochloride)[J].医药导报,2022,41(9):1401-1407.
[6]
国家药品监督管理局药品审评中心.药物临床试验登记与信息公示平台[EB/OL].[2022-02-02]. http://www.chinadrugtrials.org.cn/clinicaltrials.searchlistdetail.dhtml.
[7]
Eisai Co., Ltd.有价证券报告书・半年报告书・季度报告书[EB/OL].[2022-02-14].https://www.eisai.co.jp/ir/library/securities/pdf/pdf111fr_3.pdf.
[8]
Eisai R&D Management Co., Ltd.Cyclopropane compound: WO, 2012039371A1 [P].2012-03-29.
[9]
Eisai R&D Management Co., Ltd.Methods and compounds useful in the synthesis of orexin-2 receptor antagonists: WO, 2013123240A1 [P].2013-08-22.
[10]
YOSHIDA Y, TERAUCHI T, NAOE Y, et al.Design, synthesis, and structure-activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists [J].Bioorg Med Chem, 2014, 22(21): 6071-6088.
[11]
YOSHIDA Y, NAOE Y, TERAUCHI T, et al.Discovery of (1R,2S)-2-[[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecar-boxamide(E2006): A potent and efficacious oral orexin receptor antagonist [J].J Med Chem, 2015, 58(11): 4648-4664.
[12]
Eisai R&D Management Co., Ltd.Method and compound useful in preparation of orexin-2 receptor antagonist and Lemborexant having few impurities: WO, 2020230800A1 [P].2020-11-19.
[13]
CLEMENCEAU A, THESMAR P , GICQUEL M, et al.Direct synthesis of cyclopropanes from gem-dialkyl groups through double C-H activation [J].J Am Chem Soc, 2020, 142(36): 15355-15361.
[14]
TOMOKAWA J, YAMAUCHI K.Method for manufacturing cyclopropane compound: WO, 2020050339A1 [P].2020-03-12.
[15]
YU R R, CAI S Z, LI C, et al.Nickel-catalyzed asymmetric hydroaryloxy- and hydroalkoxycarbonylation of cyclopropenes [J].Angew Chem Int Ed Engl, 2022, 61(36): e202200733.
[16]
沈冀钧,穆永乐,吴志鑫.一种莱博雷生中间体的制备方法:中国,116836120A [P].2023-10-03.
[17]
沈冀钧,程虎,穆永乐.莱博雷生及其中间体化合物的制备方法:中国,116836150A [P].2023-10-03.
[18]
沈冀钧,程虎,胡存良.莱博雷生及其中间体的制备方法:中国,116836151A [P].2023-10-03.
[19]
沈冀钧,穆永乐,胡存良.莱博雷生及其中间体化合物的制备方法:中国,116836152A [P].2023-10-03.
2024年第55卷第5期
30
8
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.05.003
  • 接收时间:2023-10-12
  • 首发时间:2026-11-18
  • 出版时间:2024-05-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-10-12
基金
作者信息
    鲁南制药集团股份有限公司,山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400

通讯作者:

张贵民(1969—),男,研究员,从事药物研发及工程化的研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.05.003
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏